Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANAPC1 pseudogene 2 (ANAPC1P2) is classified as a pseudogene, meaning it is a non-coding DNA sequence similar to the anaphase promoting complex subunit 1 (ANAPC1) gene but does not code for a functional protein product. It is listed in gene databases (e.g., GeneCards, BioGPS) as a pseudogene, located on chromosome 2 (NCBI Gene ID: 285074), with no evidence for protein-coding potential or direct biological function[4][5]. Pseudogenes such as ANAPC1P2 are not therapeutic targets, do not act as receptors, enzymes, or other druggable molecules, and have no established relevance in human disease or pharmacology. *Note: This entry is not a valid therapeutic or pharmacological target and serves only as a genomic annotation. If information on the true functional gene (ANAPC1) is required, refer instead to "anaphase promoting complex subunit 1 (ANAPC1)," which is a functional cell cycle regulator protein[1][2][3].*
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANAPC1 pseudogene 2 (ANAPC1P2).